How have PRM shares performed in 2024?

Proteome Sciences' stock was trading at GBX 4.53 at the start of the year. Since then, PRM stock has decreased by 32.7% and is now trading at GBX 3.05. View the best growth stocks for 2024 here .

How were Proteome Sciences' earnings last quarter?

Proteome Sciences plc (LON:PRM) issued its earnings results on Monday, August, 10th. The company reported ($0.17) EPS for the quarter.

What other stocks do shareholders of Proteome Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Proteome Sciences investors own include ValiRx (VAL) , boohoo group (BOO) , Mondi (MNDI) , Petrofac (PFC) , Lloyds Banking Group (LLOY) , Falanx Group (FLX) , Quanterix (QTRX) , Centrica (CNA) , CyanConnode (CYAN) and Eckoh (ECK) .

How do I buy shares of Proteome Sciences?

Shares of PRM stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. Compare Top Brokerages Here .

LON:PRM

Proteome Sciences (PRM) Share Price, News & Analysis

→ This consistently signaled gains of 453%... 610%... and even 1036%... (From Insiders Exposed) (Ad)

Free PRM Stock Alerts

GBX 3.05

-0.09 (-2.87%)

(As of 04/18/2024 ET)

Compare

Today's Range: 2.91
▼
3.60
50-Day Range: 2.82
▼
4.50
52-Week Range: 2.65
▼
8.79

Volume: 247,243 shs
Average Volume: 158,658 shs
Market Capitalization: £9.00 million

P/E Ratio: 418.00
Dividend Yield: 6.17%
Price Target: N/A

Stock Analysis Chart Competitors Headlines

Get Proteome Sciences alerts:

Ad The Bull Report

Healthcare Takes A Big Step Forward With The Help Of AI

The average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+.

Click here to see why this small company is trusted by the Mayo Clinic

About Proteome Sciences Stock (LON:PRM)

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. It offers SysQuant provides comprehensive analysis of protein activity across regulatory and signaling pathways; TMT MS2 for analyzing cells and tissues when no phosphopeptide enrichment is required; and TMT MS3, a method for biomarker discovery in plasma and other complex samples where quantitative accuracy is the important factor. The company also provides TMT Calibrator that analyzes diseased or treated tissue in parallel with peripheral fluids; TMT SRM, a targeted assay format that enables the rapid validation of biomarker candidates; and SRM assay, a targeted mass spectrometry assay format for the routine measurement of biomarkers, as well as bioinformatics tools. It primarily serves pharmaceutical and biotechnology companies, and academic research institutes. The company was incorporated in 1993 and is based in Cobham, the United Kingdom.

PRM Stock Price History

30 days | 90 days | 365 days | Advanced Chart

PRM Stock News Headlines

April 12, 2024 | americanbankingnews.com

Proteome Sciences (LON:PRM) Share Price Crosses Below Two Hundred Day Moving Average of $4.90

April 11, 2024 | msn.com

Consumer microbiome startup Seed Health is rolling its profits into an AI science moonshot

April 18, 2024 | DTI (Ad)

Don’t expose yourself to stocks during the week

The S&P 500 just crossed below the 200 day moving average… The Nasdaq is bleeding out… Are we headed for a recession?! If you’ve been in the stock market the last few months, it hasn’t been fun… But what if I told you there was a way to target “BONUS” income just by doing a unique type of trade over the weekend? When the markets are closed. And volatility is minimal.

March 22, 2024 | msn.com

Researchers analyze how the proteome of specific brain cells changes as we age

March 20, 2024 | uk.finance.yahoo.com

Proteome Sciences PLC (PRM.AQ)

January 22, 2024 | finance.yahoo.com

If EPS Growth Is Important To You, Proteome Sciences (LON:PRM) Presents An Opportunity

January 4, 2024 | proactiveinvestors.com.au

Proteome Sciences opens lab in San Diego

January 2, 2024 | proactiveinvestors.com

Proteome Sciences opens lab in San Diego’s biotech hub

April 18, 2024 | Darwin (Ad)

2024's Must-Have Guide: Master Crypto Investment Today

The cryptocurrency revolution is here with Bitcoin soaring past the $70,000 milestone—a clear indicator of the booming digital currency market. Are you prepared to navigate these exciting yet complex waters? Introducing "Navigating the Future: A Comprehensive Guide to Cryptocurrency Investments in 2024." This free digital guide is your essential resource for understanding and capitalizing on cryptocurrency investments, tailored for both newcomers and seasoned investors. (**By clicking the link you are subscribing to The Conservative Investor Newsletter and may receive up to 2 additional free bonus subscriptions. Unsubscribing is easy.)

October 2, 2023 | lse.co.uk

Proteome Sciences sees shares surge on SysQuant service launch

August 25, 2023 | uk.investing.com

FTSE 100 Live: Stocks extend gains ahead of Jackson Hole

August 25, 2023 | marketwatch.com

Proteome Sciences Shares Fall After Swing to Loss on Higher Costs

August 15, 2023 | finance.yahoo.com

We Ran A Stock Scan For Earnings Growth And Proteome Sciences (LON:PRM) Passed With Ease

May 17, 2023 | marketwatch.com

Proteome Sciences Says It Is Well-Positioned for 2023 Growth

May 12, 2023 | lse.co.uk

Proteome Sciences expanding to US with San Diego facility

April 29, 2023 | fool.co.uk

Proteome Sciences

March 8, 2023 | finance.yahoo.com

Does Proteome Sciences (LON:PRM) Deserve A Spot On Your Watchlist?

January 25, 2023 | finanznachrichten.de

Advanced Proteome Therapeutics Corp.: Advanced Proteome Therapeutics Announces Its Proposed Plan of Arrangement

August 30, 2022 | finance.yahoo.com

Here's Why Proteome Sciences (LON:PRM) Has Caught The Eye Of Investors

August 5, 2022 | lse.co.uk

Proteome reaches milestone in launch of proteomics service

May 17, 2022 | lse.co.uk

Proteome Sciences maintains strong order book

December 14, 2021 | apnews.com

Biognosys Expands Co-Marketing Agreement with Global Life Science Leader to Advance Proteomics

December 7, 2021 | finance.yahoo.com

Here's Why I Think Proteome Sciences (LON:PRM) Might Deserve Your Attention Today

November 15, 2021 | finance.yahoo.com

Thermo Fisher Scientific Advances Proteomics Through Select Collaborations and New Analytical Instrument Solutions

September 6, 2021 | finance.yahoo.com

A Look At The Fair Value Of Proteome Sciences plc (LON:PRM)

See More Headlines

Receive PRM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Proteome Sciences and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 8/10/2020
Today: 4/18/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: LON
Sector: Medical
Industry: Diagnostics & Research
Sub-Industry: N/A
Current Symbol: LON:PRM
CUSIP: N/A
CIK: N/A
Web: www.proteomics.com
Phone: +44-20-70432116
Fax: N/A
Employees: 29
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: 418.00
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: £1.32 million
Net Margins: 8.83%
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: 7.35%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 0.49
Quick Ratio: 0.37

Sales & Book Value

Annual Sales: £7.75 million
Price / Sales: 1.16
Cash Flow: GBX 0.82 per share
Price / Cash Flow: 3.73
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 295,180,000
Free Float: N/A
Market Cap: £9.00 million
Optionable: Not Optionable
Beta: -0.03

7 Energy Stocks to Buy and Hold Forever

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Key Executives

Dr. Mariola Sohngen (Age 63)
CEO & Executive Director
Comp: $310k
Mr. Abdelghani Omari (Age 48)
CFO & Director
Comp: $209k
Dr. Ian H. Pike (Age 60)
Chief Scientific Officer & Executive Director
Comp: $233k
Mr. Richard Paul Dennis (Age 66)
Chief Commercial Officer & Executive Director
Comp: $235k
Mr. Glenn Barney
Vice President of Sales & Marketing
Victoria Joanna Birse
Company Secretary

Key Competitors

View All Competitors

PRM Stock Analysis - Frequently Asked Questions

How have PRM shares performed in 2024?: Proteome Sciences' stock was trading at GBX 4.53 at the start of the year. Since then, PRM stock has decreased by 32.7% and is now trading at GBX 3.05.
View the best growth stocks for 2024 here.
How were Proteome Sciences' earnings last quarter?: Proteome Sciences plc (LON:PRM) issued its earnings results on Monday, August, 10th. The company reported ($0.17) EPS for the quarter.
What other stocks do shareholders of Proteome Sciences own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Proteome Sciences investors own include ValiRx (VAL), boohoo group (BOO), Mondi (MNDI), Petrofac (PFC), Lloyds Banking Group (LLOY), Falanx Group (FLX), Quanterix (QTRX), Centrica (CNA), CyanConnode (CYAN) and Eckoh (ECK).
How do I buy shares of Proteome Sciences?: Shares of PRM stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:PRM) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial